AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIAID

Restructuring NIAID’s HIV/AIDS Clinical Trials Networks

Future Directions for NIAID HIV Research

Over the next several weeks, the National Institute of Allergy and Infectious Diseases (NIAID) will post a series of entries here on AIDS.gov related to planning for the future of NIAID’s HIV/AIDS clinical trial networks. The awards supporting the six current HIV/AIDS networks are set to expire in 2013 and 2014. Building on the success…

Pursuing a “Cure” for HIV/AIDS – Two Distinct Approaches

Dr. Carl Dieffenbach, PhD

Contrary to what you may have heard or read on the Internet, there is currently no cure for HIV/AIDS. While some say that there may never be a cure, I believe there is reason for hope. That’s because some of our best scientists are working on two distinct approaches to finding a cure for HIV/AIDS,…

Keeping it Real: Understanding the Changing Landscape of HIV/AIDS Clinical Trials Communication

blog.aids.gov

Earlier this month we presented at a symposium of the HIV/AIDS Network Coordination Project’s (HANC) Communications Working Group. We asked Amy Ragsdale, HANC Special Projects Coordinator to tell us a little more about the Working Group and how they are using new media. The HIV/AIDS Network Coordination (HANC) works with the six HIV/AIDS clinical trials…

Drug Regimen with Short Pauses Controls HIV and Could Lower Costs, Toxicity

blog.aids.gov

Antiretroviral drugs for HIV infection usually are taken daily, and interrupting treatment for long periods of time has proven detrimental. However, a clinical trial in Uganda has found that pausing antiretroviral therapy (ART) for just two days every week is at least as effective as taking ART continuously over a 72-week period. In addition, the…

Putting TLC+ to the Test

Listen:

Javascript and flash are required to play this audio file.

Download MP3
Dr. Carl Dieffenbach, PhD

If we routinely test everyone for HIV and treat those who are infected, could we bring an end to the HIV/AIDS epidemic? The test and treat concept, modeled on data from South Africa by scientists at the World Health Organization, is a provocative HIV prevention strategy. According to mathematical modeling, a successfully implemented test and…

Renewed Hope for an HIV Vaccine

Dr. Carl Dieffenbach, PhD

In late September, the U.S. federal government announced news on HIV vaccine research that sparked interest around the world. A trial called RV144, or the Thai HIV vaccine clinical trial , showed that the experimental vaccine regimen was safe and about 31 percent effective in preventing HIV infection. Although the vaccine regimen had a very…

Dr. Anthony S. Fauci’s Statement for National Gay Men’s HIV/AIDS Awareness Day

Dr. Anthony Fauci

Last Sunday, September 27, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease, National Institutes of Health, released a statement to acknowledge National Gay Men’s HIV/AIDS Awareness Day and research issues impacting gay men. To read the entire statement, visit the NIAID website. Anthony S. Fauci, M.D., Director of NIAID Gay…

HIV Vaccine Regimen Demonstrates Modest Preventive Effect in Thailand Clinical Study

blog.aids.gov

In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand. Following a final analysis of the trial data, the Surgeon General of the U.S. Army, the trial sponsor, announced…

Page 8 of 9« First...6789